Cumberland Pharmaceuticals (CPIX) Integrates Commercial Business with Apotex

On April 23, 2026, Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) agreed to merchantability its branded pharmaceutical portfolio to an affiliate of Apotex for $100M successful cash, with the companies readying to signifier a specialty medicines platform. The transaction is taxable to shareholder approval. Cumberland volition clasp its pipeline and its bulk involvement successful Cumberland Emerging Technologies. The institution continues to make ifetroban and has reported Phase II results successful cardiomyopathy associated with Duchenne muscular dystrophy, with FDA discussions ongoing. The programme holds Orphan Drug, Rare Pediatric Disease, and Fast Track designations.

On April 16, 2026, Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) received FDA support to grow the denotation for Caldolor to see postoperative pain. The merchandise is indicated for big and pediatric patients ages 3 months and older for mild to mean pain, mean to terrible symptom arsenic an adjunct to opioid analgesics, and the simplification of fever.

Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) acquires, develops, and commercializes medicine pharmaceutical products.

While we admit the imaginable of CPIX arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 33 Stocks That Should Double successful 3 Years and Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy. 

Disclosure: None. Follow Insider Monkey connected Google News.